Skip to content

ELECTROLYTES

DRUG13 trials

Sponsors

Amgen Inc., Region Uppsala, Oslo University Hospital HF, Assistance Publique Hopitaux De Paris, Hospital Universitari De Girona Doctor Josep Trueta

Conditions

AnemiaBRONCHIECTASIACytoreductive surgery with hyperthermic intraperitoneal chemotherapyElectrolyte ImbalanceHealth status ASA1 or ASA2 as categorised by a medical doctor at the hospital based on medical history and physical examination. The American Society of Anesthesiologists physical status (ASA1: "HealthyHip fractureLimited-Stage Small-Cell Lung Cancer (LS SCLC)Osteoporosis

Phase 2

Phase 3

A Randomized, Open-label, Phase 3 Study of Tarlatamab Compared With Standard of Care in Subjects With Relapsed Small Cell Lung Cancer After Platinum-based First-line Chemotherapy (DeLLphi-304)
Active, not recruitingCTIS2022-502669-14-00
Amgen Inc.Small cell lung cancer (SCLC)
Start: 2023-12-18Target: 199Updated: 2026-01-22
Improved Recovery by Iron following Surgery with blood loss, a double-blind multi-centre randomized controlled phase III drug trial (the IRIS-trial)
RecruitingCTIS2022-502776-22-00
Region UppsalaAnemia
Start: 2024-09-05Target: 338Updated: 2024-03-13
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS SCLC) who Have not Progressed Following Concurrent Chemoradiation Therapy (DeLLphi-306)
RecruitingCTIS2023-506235-15-00
Amgen Inc.Limited-Stage Small-Cell Lung Cancer (LS SCLC)
Start: 2024-11-07Target: 145Updated: 2025-11-17
ALBU-CHIP - Efficacy of human 20% albumin solution + Ringer Lactate versus Ringer Lactate for fluid replacement strategy during cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy : a randomized clinical trial
RecruitingCTIS2024-510943-76-00
Assistance Publique Hopitaux De ParisCytoreductive surgery with hyperthermic intraperitoneal chemotherapy
Start: 2025-09-03Target: 140Updated: 2025-08-27
Paracervical block with ropivacaine for pain relief in second trimester medical abortion - a double blind placebo controlled randomized trial
Not yet recruitingCTIS2025-524599-52-03
Karolinska Institutetabortion
Target: 132Updated: 2026-07-17

Phase 4

Unknown Phase